Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind Randomized Parallel Group Study of Alfuzosin 10mg OD Versus Placebo in the Management of Acute Urinary Retention in Patients With a First Episode Due to Benign Prostatic Hyperplasia (BPH)

NCT00290030 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00290030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00290030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind Randomized Parallel Group Study of Alfuzosin 10mg OD Versus Placebo in the Management of Acute Urinary Retention in Patients With a First Episode Due to Benign Prostatic Hyperplasia (BPH)
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2001
Completion date
October 31, 2004
Enrollment
800 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute urinary retention, prostatic hyperplasia